Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meenal Mehrotra

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Research|April 11, 2022
Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell FunctionParamita Chakraborty, Rasesh Y Parikh, Seungho Choi, et al.
Cell Reports|August 15, 2019
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor ActivityParamita Chakraborty, Silvia G Vaena, Krishnamurthy Thyagarajan, et al.
Cell Metabolism|November 14, 2017
CD38-NAD<sup>+</sup>Axis Regulates Immunotherapeutic Anti-Tumor T Cell ResponseShilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty, et al.
Nature Communications|June 2, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axisParamita Chakraborty, Shilpak Chatterjee, Mohamed Faisal Kassir, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Research|April 11, 2022
Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell FunctionParamita Chakraborty, Rasesh Y Parikh, Seungho Choi, et al.
Cell Reports|August 15, 2019
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor ActivityParamita Chakraborty, Silvia G Vaena, Krishnamurthy Thyagarajan, et al.
Cell Metabolism|November 14, 2017
CD38-NAD<sup>+</sup>Axis Regulates Immunotherapeutic Anti-Tumor T Cell ResponseShilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty, et al.
Nature Communications|June 2, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axisParamita Chakraborty, Shilpak Chatterjee, Mohamed Faisal Kassir, et al.
Pageof 3